Westminster Health Forum

We are continuing to organise full-scale virtual conferences which retain all the features of physical seminars, including full programmes, presentations with slides, panel discussions and live delegate questions and comments sessions, person-to-person and group networking, and a permanent record provided to all delegates afterwards. New events are coming on to our conference programme all the time, so there are plenty of opportunities to join us if you haven’t already, from wherever you are.
For booking-related queries or information on speaking please email us at info@forumsupport.co.uk, or contact us: +44 (0)1344 864796.

If you’re already booked on, joining instructions can be accessed from five working days before your conference via the booking dashboard. Need help? You can contact our Delegate Relations team at delegate.relations@forumsupport.co.uk or by calling the above number.

Next steps for the UK life sciences sector - policy and regulation, funding and investment, collaboration and the mission approach, evidence and clinical trials, and patient access to innovation

Morning, Tuesday, 19th July 2022


This conference focuses on the future for UK life sciences in the UK.


It will be an opportunity to assess changes to regulation and evaluation - and the support, frameworks, partnerships and investment required for the life sciences industry to navigate the way forward.


Areas for discussion include the use of data and real-world evidence, efficiencies within clinical trials, and taking a mission-led approach to healthcare challenges.


Delegates will also examine priorities for sector investment, funding and growth, with the new Life Sciences Innovative Manufacturing Fund, and in the context of:

  • the Innovative Medicines Fund
  • the plans for the sector set out by the Government in the Life Sciences Vision
  • the industry moving forward on the back of developments during the COVID-19 pandemic

Areas for discussion include:

  • Life Sciences Vision - implementation of strategic ambitions - priorities for channelling investment 
  • mission-led approach - stakeholder collaboration - targeting investment and funding - learning from the development of the COVID-19 vaccine
  • sector growth - support for innovation and manufacturing - government funding - developing the business environment to support growth and healthcare ambitions - global competitiveness
  • new approaches to evaluation - effective stakeholder use of regulatory flexibility - frameworks for data use to support new methods
  • clinical trials - opportunities to address bureaucracy - improving efficiency & participation - accessing harder-to-reach population groups
  • data & real-world evidence - providing clarity on what is needed for the sector to capitalise on potential
  • personalised, predictive & preventative health care - next steps - improving patient access - commercialisation - tackling inequality in health outcomes

We are very pleased to be able to include keynote sessions with Rosalind Campion, Director, Office for Life Sciences; and Dr Jennifer Harris, Director of Research Policy, ABPI.


The discussion is bringing together stakeholders with key policy officials who are due to attend from DHSC; Department of Health, NI; GO-Science; HM Treasury; House of Commons Library; and The Scottish Government.



Keynote Speaker

Dr Jennifer Harris

Director of Research Policy, ABPI

Keynote Speakers

Rosalind Campion

Director, Office for Life Sciences

Dr Jennifer Harris

Director of Research Policy, ABPI

Chair

Baroness Finlay of Llandaff

Vice-Chair, All-Party Parliamentary Group on Cancer

Speakers

Dr Suki Balendra

Life Sciences Lead, Imperial College Healthcare NHS Trust

Sarah Woolnough

Chief Executive, Asthma UK and British Lung Foundation Partnership

Evren Kemal

Associate Director, Research and Innovation, Medical Affairs Excellence, MSD

Professor Teresa Lambe

Professor of Vaccinology & Immunology, Oxford Vaccine Group, University of Oxford

Andrew Davies

Digital Health Lead, ABHI

Karen Skinner

Chief Project and Portfolio Officer, LifeArc

Dr Douglas Clark

Medical Director, Boehringer Ingelheim UK and Ireland

Angela McFarlane

Vice President, Strategic Planning Northern Europe, IQVIA

Hannah Davies

Head of External Affairs, Northern Health Science Alliance

Karen Taylor

Director, Centre for Health Solutions, Deloitte

Doris-Ann Williams

Chief Executive, BIVDA